Oncology Acute Care Follow-up Intervention Study, Parkland Health, NCT07550192
ClinicalTrials.gov Studies
Summary
This pragmatic randomized controlled trial (NCT07550192) evaluates an education intervention designed to increase patient engagement with Oncology Acute Care (OAC) services among cancer patients at Parkland Health. Patients are randomized to control (usual care) or intervention arms, with the intervention receiving automated MyChart messages and texts at 24, 48, and 72 hours post-discharge. Follow-up occurs at 3-month intervals until an outcome is documented.
“This pragmatic randomized controlled study evaluates an education intervention designed to increase patient engagement with Oncology Acute Care (OAC) services among patients being treated for cancer at Parkland Health.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
This document registers a new pragmatic randomized controlled clinical trial on ClinicalTrials.gov. The study evaluates whether automated follow-up messages (MyChart and SMS) at 24, 48, and 72 hours post-discharge improve patient engagement with Oncology Acute Care services among cancer patients at Parkland Health. Eligible participants are randomized to control or intervention arms, with crossover provisions if control patients have a treatment-related ED visit without documented OAC engagement.
For healthcare providers and clinical investigators, this registry entry indicates an active research program focused on care coordination and patient engagement interventions in oncology settings. The study's crossover design and 3-month follow-up intervals suggest a focus on measuring downstream healthcare utilization outcomes (ED visits, OAC contacts). Institutions with similar patient populations may wish to monitor study findings for potential care coordination insights.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Oncology Acute Care Follow-up Intervention Study
N/A NCT07550192 Kind: NA Apr 24, 2026
Abstract
This pragmatic randomized controlled study evaluates an education intervention designed to increase patient engagement with Oncology Acute Care (OAC) services among patients being treated for cancer at Parkland Health.
Eligible patients will be randomized to either a control (usual care) arm or an intervention arm. If a patient in the control group has experiences a subsequent cancer treatment related ED visit without documented OAC engagement, they will be moved to the intervention arm. Patients in the intervention arm will receive an automated MyChart message and text message within 24 hours of hospital discharge reinforcing oncology acute care (OAC) resources, including contact information for the triage line and guidance for when to seek urgent versus emergency care. Messages will be resent at 48 and 72 hours if unviewed. Once the message is viewed, the patient will enter an outcome tracking period to monitor time to subsequent ED visit or OAC contact. Follow-up will occur in 3-month intervals until an outcome is documented or the study ends.
After randomization, patients will be monitored on an observation list for outcomes including OAC contact and cancer treatment-related Emergency Department (ED) visits. Patients who contact OAC clinic will be removed from observation list and complete the study. We will repeat the observation period and document outcomes if the patient has a subsequent cancer treatment-related ED visits without documented OAC engagement.
Conditions: Cancer
Interventions: Follow-up messaging
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.